Project Grant HT94252510776
Award Date
8/1/25
Completion Date
7/31/27
Dollars Obligated
$406K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
This federal Project Grant award of $1,170,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by the Regents of the University of Michigan to develop systemically administered bispecific antibodies that activate neurotrophin receptors for treating noise-induced inner ear damage. The award period runs from May 15, 2025 to May 14, 2028. The Military Medical Research and Development program funds advanced biomedical research...
The U.S. Defense Health Agency awarded a $320,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Regents of the University of Michigan. The grant, titled "IMPACT OF THE INTEGRATED STRESS RESPONSE ON VISUAL SYNAPTIC CIRCUITS IN MULTIPLE SCLEROSIS", will support advanced biomedical research focused on transforming healthcare for military service members, veterans, and the broader public. The research, to be conducted from September 1,...
This federal Project Grant award of $932,498.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. Specifically, the award to the Regents of the University of Michigan will fund a research project titled "Non-Invasive CNS Delivery of Immunocytokines for Sustained Expansion of Tregs and Treatment of ALS". The research...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $1,100,747.00 to the Regents of the University of Michigan to conduct research on "PROTEIN ENGINEERING OF ANTIBODY-DRUG CONJUGATES TO COORDINATE THE INNATE AND ADAPTIVE IMMUNE SYSTEMS FOR CURATIVE RESPONSES." The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical...
This $426,400 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at the University of Chicago to conduct nanoscale structural and molecular mapping of the optic nervous system following ocular blast. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing understanding of the impact of ocular blast injuries on the nervous system. The award...
This federal Project Grant award of $1,148,334.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research at the University of Pittsburgh aimed at developing viral delivery strategies for targeted hair cell regeneration. The research seeks to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical solutions to critical health challenges. The...
This federal Project Grant award for $1,399,812.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The grant is awarded to the Regents of the University of Minnesota to conduct research on outcomes and late effects in pediatric and adolescent germ cell tumor survivors. This funding will enable...
The Regents of the University of Michigan received a $312,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 2-year grant, awarded on February 1, 2024, supports research to investigate "An Unexpected Role for the Ubiquitin Proteasome System in Repeat Associated Non-AUG Translation." This basic and translational biomedical research aims to advance understanding and treatment of neurological disorders...
This Project Grant award of $546,000.00 from the Defense Health Agency supports research at the Regents of the University of Michigan to develop a novel lectin for targeting T-cell lymphomas. The award is part of the Military Medical Research and Development program (CFDA 12.420), which funds basic, applied, and advanced biomedical research to transform healthcare for service members and the public through innovative and impactful research. The 3-year award began on September 1, 2023 and will...
The federal Project Grant award of $624,000.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of Michigan to investigate the role of epithelial AIM2 in Helicobacter pylori-associated gastric preneoplasia. The award, effective from July 15, 2025 to July 14, 2027, will fund advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public....